DemarestSTWhiteheadMTTurnaciogluSPearlPLGropmanAL.Phenotypic analysis of epilepsy in the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes-associated mitochondrial DNA A3243G mutation. J Child Neurol. 2014;29:1249–1256.
2.
HsuYCYangFCPerngCL. Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome presenting as acute meningoencephalitis: a case report. J Emerg Med. 2012;43:e163–e166.
3.
Okhuijsen-KroesEJTrijbelsJMSengersRC. Infantile presentation of the mtDNA A3243G tRNA(Leu (UUR)) mutation. Neuropediatrics. 2001;32:183–190.
4.
FeigenbaumAChitayatDRobinsonB. The expanding clinical phenotype of the tRNA(Leu(UUR)) A→G mutation at np 3243 of mitochondrial DNA: diabetic embryopathy associated with mitochondrial cytopathy. Am J Med Genet. 1996;62:404–409.
5.
Pérez López-FraileMIBarrenaRMontoyaJMartaE. Evolution until death of two members of a family with A3243G mutation and MELAS phenotype versus diabetes mellitus. Neurologia. 2006;21:327–332.
6.
PavlakisSGPhillipsPCDiMauroS. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481–488.
7.
FujimotoSMizunoKShibataH. Serial electroencephalographic findings in patients with MELAS. Pediatr Neurol. 1999;20:43–48.
8.
BertrandEFidziańskaASchmidt-SidorBMendelT. Mitochondrial encephalomyopathy of mixed MELAS type. Folia Neuropathol. 1996;34:193–198.
9.
HsiehFGohhRDworkinL. Acute renal failure and the MELAS syndrome, a mitochondrial encephalomyopathy. J Am Soc Nephrol. 1996;7:647–652.
10.
TakahashiSTohgiHYonezawaH. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci. 1998;158:58–64.
11.
Durand-DubiefFRyvlinPMauguièreF. Polymorphism of epilepsy associated with the A3243G mutation of mitochondrial DNA (MELAS): reasons for delayed diagnosis. Rev Neurol (Paris). 2004;160:824–829.
12.
KomlósiKKellermayerRMaászA. Maternally inherited deafness and unusual phenotypic manifestations associated with A3243G mitochondrial DNA mutation. Pathol Oncol Res. 2005;11:82–86.
13.
TamEWFeigenbaumAAddisJB. A novel mitochondrial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis. Neuropediatrics. 2008;39:328–334.
14.
YoshidaTOuchiAMiuraD. MELAS and reversible vasoconstriction of the major cerebral arteries. Intern Med. 2013;52:1389–1392.
15.
SofouKStenerydKWiklundLM. MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement. Mitochondrion. 2013;13:364–371.
16.
DegoulFDiryMPou-SerradellA. Myo-leukoencephalopathy in twins: study of 3243-myopathy, encephalopathy, lactic acidosis, and strokelike episodes mitochondrial DNA mutation. Ann Neurol. 1994;35:365–370.
17.
SteriadeCAndradeDMFaghfouryH. Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet. Pediatr Neurol. 2014;50:498–502.
18.
LampertiCDiodatoDLamanteaE. MELAS-like encephalomyopathy caused by a new pathogenic mutation in the mitochondrial DNA encoded cytochrome c oxidase subunit I. Neuromuscul Disord. 2012;22:990–994.
19.
FinstererJZarrouk MahjoubS. Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. Expert Opin Drug Metab Toxicol. 2012;8:71–79.
